(Q46791717)

English

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers.

scientific article published on 3 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Phase II trial of imatinib mesylate in patients with recurrent platinum- and taxane-resistant epithelial ovarian and primary peritoneal cancers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Diane C. Bodurka

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Charles F. Levenback

7

object named as

Charles F Levenback

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

David Gershenson

8

object named as

David M Gershenson

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Robert L Coleman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Russell R Broaddus

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Judith K Wolf

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Thomas W Burke

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

John J Kavanagh

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

language of work or name

0 references

publication date

3 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

101

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

126-131

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Treatment of gastrointestinal stromal tumors with imatinib mesylate: a major breakthrough in the understanding of tumor-specific molecular characteristics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Targeting the platelet-derived growth factor receptor in antivascular therapy for human ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and Akt inactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

The effects of platelet-derived growth factor and receptor on normal and neoplastic human ovarian surface epithelium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Abl expression in human fetal and adult tissues, tumours, and tumour microvessels

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Expression and action of kit ligand/stem cell factor in normal human and bovine ovarian surface epithelium and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Lack of expression of c-KIT in ovarian cancers is associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Human ovarian tumors of epithelial origin express PDGF in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

A phase II trial of imatinib mesylate in patients with prostate specific antigen progression after local therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Blockade of platelet-derived growth factor receptor-beta by CDP860, a humanized, PEGylated di-Fab', leads to fluid accumulation and is associated with increased tumor vascularized volume.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.041

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.09.041

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16271384%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46791717&oldid=2034404881"